Matches in Nanopublications for { ?s ?p "[Collectively, our current results suggest that USP22 may act as an oncogene in CRC as it positively regulates cell cycle via both BMI-1-mediated INK4a/ARF pathway and Akt signaling pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- NP268784.RAWKoYXUDDfhakdUzO4bsxIRPHI4MdbazbdXEAMjvmn-E130_assertion description "[Collectively, our current results suggest that USP22 may act as an oncogene in CRC as it positively regulates cell cycle via both BMI-1-mediated INK4a/ARF pathway and Akt signaling pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP268784.RAWKoYXUDDfhakdUzO4bsxIRPHI4MdbazbdXEAMjvmn-E130_provenance.
- NP870838.RAcdYPqzTA84QvFUKi7g0gkz6Oz9hLfnh1wf4cb6SaJxo130_assertion description "[Collectively, our current results suggest that USP22 may act as an oncogene in CRC as it positively regulates cell cycle via both BMI-1-mediated INK4a/ARF pathway and Akt signaling pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP870838.RAcdYPqzTA84QvFUKi7g0gkz6Oz9hLfnh1wf4cb6SaJxo130_provenance.
- NP543470.RANqYgmN4niI405Zn5Qw3CPhC0BFlgIxVeRK6rQJTOujw130_assertion description "[Collectively, our current results suggest that USP22 may act as an oncogene in CRC as it positively regulates cell cycle via both BMI-1-mediated INK4a/ARF pathway and Akt signaling pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP543470.RANqYgmN4niI405Zn5Qw3CPhC0BFlgIxVeRK6rQJTOujw130_provenance.
- NP641166.RAIliBC5uCe2Xwb89PtO7iYMq-SHtaAlUm5_Vh7UjWSBA130_assertion description "[Collectively, our current results suggest that USP22 may act as an oncogene in CRC as it positively regulates cell cycle via both BMI-1-mediated INK4a/ARF pathway and Akt signaling pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP641166.RAIliBC5uCe2Xwb89PtO7iYMq-SHtaAlUm5_Vh7UjWSBA130_provenance.
- NP268419.RAlBXzcd0AwmwN2KBd7z3n8mRzdyJpkgvc6ujib3ueVj8130_assertion description "[Collectively, our current results suggest that USP22 may act as an oncogene in CRC as it positively regulates cell cycle via both BMI-1-mediated INK4a/ARF pathway and Akt signaling pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP268419.RAlBXzcd0AwmwN2KBd7z3n8mRzdyJpkgvc6ujib3ueVj8130_provenance.
- NP924635.RARiPr62lhWemtlUkPrNhDFMqp7lMuh4Yb-zJGzZQI0kc130_assertion description "[Collectively, our current results suggest that USP22 may act as an oncogene in CRC as it positively regulates cell cycle via both BMI-1-mediated INK4a/ARF pathway and Akt signaling pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP924635.RARiPr62lhWemtlUkPrNhDFMqp7lMuh4Yb-zJGzZQI0kc130_provenance.
- NP924638.RAQ7vKU1vsJiSBkA9QXMdgHPV68BRN3OHnhdvdbz5DEA4130_assertion description "[Collectively, our current results suggest that USP22 may act as an oncogene in CRC as it positively regulates cell cycle via both BMI-1-mediated INK4a/ARF pathway and Akt signaling pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP924638.RAQ7vKU1vsJiSBkA9QXMdgHPV68BRN3OHnhdvdbz5DEA4130_provenance.
- NP1016138.RAvAK5MIyEAovtbfk3jCQvZFVUeG-QubhyiyajY8xo6Y0130_assertion description "[Collectively, our current results suggest that USP22 may act as an oncogene in CRC as it positively regulates cell cycle via both BMI-1-mediated INK4a/ARF pathway and Akt signaling pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1016138.RAvAK5MIyEAovtbfk3jCQvZFVUeG-QubhyiyajY8xo6Y0130_provenance.
- NP870869.RAHKBeVgdEruxvpPXO6SORDhUDs-3kmG1lnpiuc-5gJGY130_assertion description "[Collectively, our current results suggest that USP22 may act as an oncogene in CRC as it positively regulates cell cycle via both BMI-1-mediated INK4a/ARF pathway and Akt signaling pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP870869.RAHKBeVgdEruxvpPXO6SORDhUDs-3kmG1lnpiuc-5gJGY130_provenance.
- NP1015773.RA9wJDkAbEWpAGVEkYO2sEwQaxrliriSLzrv9IH3VpIoU130_assertion description "[Collectively, our current results suggest that USP22 may act as an oncogene in CRC as it positively regulates cell cycle via both BMI-1-mediated INK4a/ARF pathway and Akt signaling pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1015773.RA9wJDkAbEWpAGVEkYO2sEwQaxrliriSLzrv9IH3VpIoU130_provenance.
- NP924636.RA6b8itsujHIp4F6H5ABPiBsI6N1VFGnJz3By26nsjyo0130_assertion description "[Collectively, our current results suggest that USP22 may act as an oncogene in CRC as it positively regulates cell cycle via both BMI-1-mediated INK4a/ARF pathway and Akt signaling pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP924636.RA6b8itsujHIp4F6H5ABPiBsI6N1VFGnJz3By26nsjyo0130_provenance.
- NP924637.RA3xyjILzreRcF7KsD5Uhw3biT2etE5WZeDZhkOt-aeNg130_assertion description "[Collectively, our current results suggest that USP22 may act as an oncogene in CRC as it positively regulates cell cycle via both BMI-1-mediated INK4a/ARF pathway and Akt signaling pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP924637.RA3xyjILzreRcF7KsD5Uhw3biT2etE5WZeDZhkOt-aeNg130_provenance.